Better prognosis of gastric cancer patients with high levels of tumor infiltrating lymphocytes is counteracted by PD-1 expression

Better prognosis of gastric cancer patients with high levels of tumor infiltrating lymphocytes is counteracted by PD-1 expression

The prognostic potential of anti-tumor immune responses is becoming increasingly important in adenocarcinoma of the gastroesophageal junction and stomach (AGE/S) especially regarding the use of immune checkpoint inhibitors. This study analyzes for the first time the prognostic impact of tumor-infilt...

Full description

Bibliographic Details
Main Authors:	M. Pötzsch, E. Berg, M. Hummel, U. Stein, M. von Winterfeld, K. Jöhrens, B. Rau, S. Daum, C. Treese
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2020-01-01
Series:	OncoImmunology
Subjects:	gastric cancer tumor-infiltrating lymphocytes pd-1 biomarker
Online Access:	http://dx.doi.org/10.1080/2162402X.2020.1824632

Similar Items

Low Expression of Programmed Death 1 (PD-1), PD-1 Ligand 1 (PD-L1), and Low CD8+ T Lymphocyte Infiltration Identify a Subgroup of Patients With Gastric and Esophageal Adenocarcinoma With Severe Prognosis
by: Silvio Däster, et al.
Published: (2020-04-01)

EBV+ and MSI Gastric Cancers Harbor High PD-L1/PD-1 Expression and High CD8+ Intratumoral Lymphocytes
by: Simona De Rosa, et al.
Published: (2018-04-01)

PD-L1 Expression in Different Segments and Histological Types of Ovarian Cancer According to Lymphocytic Infiltrate
by: Ljubiša Jovanović, et al.
Published: (2021-11-01)

PD-L1 expression on stromal tumor-infiltrating lymphocytes is a favorable prognostic factor in ovarian serous carcinoma
by: Ki Hyung Kim, et al.
Published: (2019-06-01)

T‐cells infiltration mediates the association between neutrophil/lymphocyte ratio and survival in gastric cancer
by: Qifei He, et al.
Published: (2023-08-01)

Tumor cells PD-L1 expression as a favorable prognosis factor in nasopharyngeal carcinoma patients with pre-existing intratumor-infiltrating lymphocytes
by: Qian Zhu, et al.
Published: (2017-05-01)

Helios Expression in Tumor-Infiltrating Lymphocytes Correlates with Overall Survival of Advanced Gastric Cancer Patients
by: Wei-Ming Chen, et al.
Published: (2020-09-01)

Profiling the Tumor-Infiltrating Lymphocytes in Gastric Cancer Reveals Its Implication in the Prognosis
by: Weiqiang Yu, et al.
Published: (2022-06-01)

Clear cell ovarian cancers with microsatellite instability: A unique subset of ovarian cancers with increased tumor-infiltrating lymphocytes and PD-1/PD-L1 expression
by: Brooke E. Howitt, et al.
Published: (2017-02-01)

PD-L1 and immune infiltrates are differentially expressed in distinct subgroups of gastric cancer
by: H. K. Angell, et al.
Published: (2019-02-01)

Prognostic impact of activin subunit inhibin beta A in gastric and esophageal adenocarcinomas
by: J. J. Staudacher, et al.
Published: (2022-09-01)

Effect of Neoadjuvant Chemotherapy on Tumor-Infiltrating Lymphocytes in Resectable Gastric Cancer: Analysis from a Western Academic Center
by: Elliott J. Yee, et al.
Published: (2024-04-01)

The relationship of the tertiary lymphoid structures with the tumor-infiltrating lymphocytes and its prognostic value in gastric cancer
by: Nana Zhang, et al.
Published: (2021-08-01)

Tumor Infiltrating Lymphocyte Expression of PD-1 Predicts Response to Anti-PD-1/PD-L1 Immunotherapy
by: Nicholas J. Bevins, et al.
Published: (2022-11-01)

Lymphocytes Infiltration and Expression of PD-1 and PD-L1 in Colorectal Cancer Between HIV-Infected and Non-HIV-Infected Patients: A Propensity Score Matched Cohort Study
by: Ye Cao, et al.
Published: (2022-03-01)

PD-L1, Galectin-9 and CD8+ tumor-infiltrating lymphocytes are associated with survival in hepatocellular carcinoma
by: Kostandinos Sideras, et al.
Published: (2017-02-01)

Prognostic perspectives of PD-L1 combined with tumor-infiltrating lymphocytes, Epstein-Barr virus, and microsatellite instability in gastric carcinomas
by: Euno Choi, et al.
Published: (2020-06-01)

CD3D Is an Independent Prognostic Factor and Correlates With Immune Infiltration in Gastric Cancer
by: Li Yuan, et al.
Published: (2022-06-01)

Prognostic relevance of tumor-infiltrating lymphocytes and immune checkpoints in pediatric medulloblastoma
by: Jeroen F. Vermeulen, et al.
Published: (2018-03-01)

Evaluating the prognostic significance of tumor-infiltrating lymphocytes in solid tumor: practice of a standardized method from the International Immuno-Oncology Biomarkers Working Group
by: Liu JY, et al.
Published: (2019-07-01)

Synergistic effects of AAGL and anti-PD-1 on hepatocellular carcinoma through lymphocyte recruitment to the liver
by: Xiangdong Ye, et al.
Published: (2021-11-01)

Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte-based adoptive T cell therapy
by: Christopher Aled Chamberlain, et al.
Published: (2022-03-01)

Tumor Infiltrating Lymphocytes Signature as a New Pan-Cancer Predictive Biomarker of Anti PD-1/PD-L1 Efficacy
by: Elise Ballot, et al.
Published: (2020-08-01)

Three Cases of Lymphocytic Infiltration of the Eyelid
by: Kyoko Sugioka, et al.
Published: (2021-05-01)

Lymphocytic infiltration in helicobacter pylori gastritis
by: Fatma A. Ali*, et al.
Published: (2021-01-01)

Significance of Siglec‐15 expression in colorectal cancer: association with advanced disease stage and fewer tumor‐infiltrating lymphocytes
by: Zhao Lu, et al.
Published: (2023-03-01)

PD‐L1 and PD‐L2 expression in pancreatic ductal adenocarcinoma and their correlation with immune infiltrates and DNA damage response molecules
by: Yue Zhang, et al.
Published: (2022-05-01)

B-lymphocytic infiltration of the prostate to a patient with chronic lymphocytic leukemia. A case report
by: Ioannis Anastasiou, et al.
Published: (2017-03-01)

PD-L1, CD4+, and CD8+ Tumor-Infiltrating Lymphocytes (TILs) Expression Profiles in Melanoma Tumor Microenvironment Cells
by: Bogdan Marian Caraban, et al.
Published: (2023-01-01)

CMA1 is potent prognostic marker and associates with immune infiltration in gastric cancer
by: Shanping Shi, et al.
Published: (2020-05-01)

Relationship between consolidation tumor ratio and tumor‐infiltrating lymphocytes in small‐sized lung adenocarcinoma
by: Yuki Ono, et al.
Published: (2022-08-01)

Immune Checkpoint Molecules on Tumor-Infiltrating Lymphocytes and Their Association with Tertiary Lymphoid Structures in Human Breast Cancer
by: Cinzia Solinas, et al.
Published: (2017-10-01)

Higher Numbers of T-Bet+ Tumor-Infiltrating Lymphocytes Associate with Better Survival in Human Epithelial Ovarian Cancer
by: Yun Xu, et al.
Published: (2017-01-01)

Quantitative high-throughput analysis of tumor infiltrating lymphocytes in breast cancer
by: Kumiko Hayashi, et al.
Published: (2022-09-01)

High Endothelial Venule with Concomitant High CD8+ Tumor-Infiltrating Lymphocytes Is Associated with a Favorable Prognosis in Resected Gastric Cancer
by: Soon Auck Hong, et al.
Published: (2020-08-01)

CD8+ tumor‐infiltrating lymphocytes within the primary tumor of patients with synchronous de novo metastatic colorectal carcinoma do not track with survival
by: Rosemary Millen, et al.
Published: (2020-01-01)

A Case Report of Jessner's Lymphocytic Infiltrate Induced by Exposure
by: Omid Aminian, et al.
Published: (2009-08-01)

Immune Cell Infiltrates and Neutrophil-to-Lymphocyte Ratio in Relation to Response to Chemotherapy and Prognosis in Laryngeal and Hypopharyngeal Squamous Cell Carcinomas
by: Mario Sánchez-Canteli, et al.
Published: (2021-04-01)

Quantitative multiplex immunofluorescence analysis identifies infiltrating PD1+CD8+ and CD8+ T cells as predictive of response to neoadjuvant chemotherapy in breast cancer
by: Hongling Liang, et al.
Published: (2020-10-01)

Prognostic Value of Tumor-Infiltrating Lymphocytes and Tertiary Lymphoid Structures in Epstein-Barr Virus-Associated and -Negative Gastric Carcinoma
by: Na Cheng, et al.
Published: (2021-07-01)